观点

从进化生物学角度谈为何中国目前需要动态清零而非与新冠病毒共存

展开
  • 1. 中国科学院上海营养与健康研究所进化基因组学实验室,上海 200031
    2. 中国科学院上海巴斯德研究所,上海 200031
    3. 中山大学生命科学学院,广州 510275
    4. 云南大学,云南生物资源保护与利用国家重点实验室,昆明 650091
苏枭,博士,研究员,研究方向:呼吸道感染。E-mail: xsu@ips.ac.cn|何子文,博士,副教授,研究方向:进化生物学与生态基因组学。E-mail: heziwen@mail.sysu.edu.cn|柳树群,博士,教授,研究方向:计算生物学。E-mail: shuqunliu@gmail.com; 苏枭,何子文和柳树群并列第一作者。

收稿日期: 2022-04-13

  修回日期: 2022-04-19

  网络出版日期: 2022-04-27

基金资助

中国科学院B类战略性先导科技专项资助(XDPB17)

本文引用格式

苏枭, 何子文, 柳树群, 李海鹏 . 从进化生物学角度谈为何中国目前需要动态清零而非与新冠病毒共存[J]. 遗传, 2022 , 44(5) : 442 -446 . DOI: 10.16288/j.yczz.22-107

参考文献

[1] Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M, Choga WT, Colquhoun R, Davids M, Deforche K, Doolabh D, du PL, Engelbrecht S, Everatt J, Giandhari J, Giovanetti M, Hardie D, Hill V, Hsiao NY, Iranzadeh A, Ismail A, Joseph C, Joseph R, Koopile L, Kosakovsky Pond SL, Kraemer MUG, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells R, Lockman S, Lucaci A, Maharaj A, Mahlangu B, Maponga T, Mahlakwane K, Makatini Z, Marais G, Maruapula D, Masupu K, Matshaba M, Mayaphi S, Mbhele N, Mbulawa MB, Mendes A, Mlisana K, Mnguni A, Mohale T, Moir M, Moruisi K, Mosepele M, Motsatsi G, Motswaledi MS, Mphoyakgosi T, Msomi N, Mwangi PN, Naidoo Y, Ntuli N, Nyaga M, Olubayo L, Pillay S, Radibe B, Ramphal Y, Ramphal U, San JE, Scott L, Shapiro R, Singh L, Smith-Lawrence P, Stevens W, Strydom A, Subramoney K, Tebeila N, Tshiabuila D, Tsui J, van Wyk S, Weaver S, Wibmer C, Wilkinson E, Wolter N, Zarebski AE, Zuze B, Goedhals D, Preiser W, Treurnicht F, Venter M, Williamson C, Pybus OG, Bhiman J, Glass A, Martin DP, Rambaut A, Gaseitsiwe S, von Gottberg A, de Oliveira T. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature, 2022, 603(7902):679-686.
[2] Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, Molteni E, Canas L, Österdahl MF, Modat M, Sudre CH, Fox B, Hammers A, Wolf J, Capdevila J, Chan AT, David SP, Steves CJ, Ourselin S, Spector TD. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study. Lancet, 2022, doi: 10.1016/s0140-6736(22)00327-0
[3] Chen JM, Chen YQ. China can prepare to end its zero-COVID policy. Nat Med, 2022, doi: 10.1038/s41591-022-01794-3
[4] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature, 2020, 579(7798):265-269.
[5] Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS- CoV-2 and COVID-19. Nat Rev Microbiol, 2021, 19(3):141-154.
[6] Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol, 2020, 94(7):e00127-20.
[7] Zhang ZB, Xia YL, Shen JX, Du WW, Fu YX, Liu SQ. Mechanistic origin of different binding affinities of SARS-CoV and SARS-CoV-2 spike RBDs to human ACE2. Cells, 2022, 11(8):1274.
[8] Peng R, Wu LA, Wang Q, Qi J, Gao GF. Cell entry by SARS-CoV-2. Trends Biochem Sci, 2021, 46(10):848-860.
[9] Yu D, Yang X, Tang BX, Pan YH, Yang JN, Duan GY, Zhu JW, Hao ZQ, Mu HL, Dai L, Hu WJ, Zhang MC, Cui Y, Jin T, Li CP, Ma L, Language translation team, Su X, Zhang G, Zhao W, Li H. Coronavirus GenBrowser for monitoring the transmission and evolution of SARS- CoV-2. Brief Bioinform, 2022, 23(2): bbab583.
[10] Hartl DL, Clark AG. Principles of Population Genetics. Sinauer Associates, Inc., 1988.
[11] Lin K, Li H. Advances in detecting positive selection on genome. Hereditas (Beijing), 2009, 31(9):896-902.
[11] 林拷, 李海鹏. DNA水平上检测正选择方法的研究进展. 遗传, 2009, 31(9):896-902
[12] Anderson RM, May RM. Coevolution of hosts and parasites. Parasitology, 1982, 85(Pt 2):411-426.
[13] Bull JJ. Virulence. Evolution, 1994, 48(5):1423-1437.
[14] Ebert D, Bull JJ. Challenging the trade-off model for the evolution of virulence: is virulence management feasible? Trends Microbiol, 2003, 11(1):15-20.
[15] Read AF. The evolution of virulence. Trends Microbiol, 1994, 2(3):73-76.
[16] Geoghegan JL, Holmes EC. The phylogenomics of evolving virus virulence. Nat Rev Genet, 2018, 19(12):756-769.
[17] Levin BR, Bull JJ. Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol, 1994, 2(3):76-81.
[18] Read AF, Baigent SJ, Powers C, Kgosana LB, Blackwell L, Smith LP, Kennedy DA, Walkden-Brown SW, Nair VK. Imperfect vaccination can enhance the transmission of highly virulent pathogens. PLoS Biol, 2015, 13(7):e1002198.
[19] Ma HL, Wang ZG, Zhao X, Han J, Zhang Y, Wang H, Chen C, Wang J, Jiang FC, Lei J, Song JD, Jiang SF, Zhu SL, Liu HH, Wang DY, Meng Y, Mao NY, Wang YH, Zhu Z, Chen ZX, Wang BL, Song QQ, Du HJ, Yuan Q, Xia D, Xia ZQ, Liu PP, Wu YC, Feng ZJ, Gao RQ, Gao GF, Xu WB. Long distance transmission of SARS-CoV-2 from contaminated cold chain products to humans -- Qingdao City, Shandong Province, China, September 2020. China CDC Weekly, 2021, 3(30):637-644.
[20] Yu D, Zhu JW, Yang JN, Pan YH, Mu HL, Cao RF, Tang BX, Duan GY, Hao ZQ, Dai L, Zhao GP, Zhang YP, Zhao W, Zhang G, Li H. Global cold-chain related SARS-CoV-2 transmission. Zenodo, 2022, doi: 10.5281/zenodo.6379310.
[21] Liu PP, Yang MJ, Zhao X, Guo YY, Wang L, Zhang J, Lei WW, Han WF, Jiang FC, Liu WJ, Gao GF, Wu GZ. Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface. Biosaf Health, 2020, 2(4):199-201.
[22] Pang XH, Ren LL, Wu SS, Ma WT, Yang J, Di L, Li J, Xiao Y, Kang L, Du SC, Du J, Wang J, Li G, Zhai SG, Chen LJ, Zhou WX, Lai SJ, Gao L, Pan Y, Wang QY, Li MK, Wang JB, Huang YY, Wang JW, COVID-19 Field Response Group, COVID-19 Laboratory Testing Group. Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing. Natl Sci Rev, 2020, 7(12):1861-1864.
[23] Bolze A, Basler T, White S, Rossi AD, Wyman D, Roychoudhury P, Greninger AL, Hayashibara K, Beatty M, Shah S, Stous S, Kil E, Dai H, Cassens T, Tsan K, Nguyen J, Ramirez J, Carter S, Cirulli ET, Barrett KS, Washington NL, Belda-Ferre P, Jacobs S, Sandoval E, Becker D, Lu JT, Isaksson M, Lee W, Luo SS. Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination. medRxiv, 2022, doi: 10.1101/2022.03.09.22272113.
[24] Lacek KA, Rambo-Martin BL, Batra D, Zheng XY, Sakaguchi H, Peacock T, Keller M, Wilson MM, Sheth M, Davis ML, Borroughs M, Gerhart J, Hassell N, Shepard SS, Cook PW, Lee J, Wentworth DE, Barnes JR, Kondor R, Paden CR. Identification of a novel SARS-CoV-2 Delta-Omicron recombinant virus in the United States. bioRxiv, 2022, doi: 10.1101/2022.03.19.484981.
[25] Willyard C. What the Omicron wave is revealing about human immunity. Nature, 2022, 602(7895):22-25.
[26] Zhao SL, Sha T, Wu CI, Xue YB, Chen H. Will the large- scale vaccination succeed in containing the COVID-19 pandemic and how soon? Quantitative Biology, 2021, 3:304-316.
[27] Gong Z, Zhu JW, Li CP, Jiang S, Ma LN, Tang BX, Zou D, Chen ML, Sun YB, Song SH, Zhang Z, Xiao JF, Xue YB, Bao YM, Du ZL, Zhao WM. An online coronavirus analysis platform from the National Genomics Data Center. Zool Res, 2020, 41(6):705-708.
文章导航

/